JP2022527638A5 - - Google Patents
Info
- Publication number
- JP2022527638A5 JP2022527638A5 JP2021560323A JP2021560323A JP2022527638A5 JP 2022527638 A5 JP2022527638 A5 JP 2022527638A5 JP 2021560323 A JP2021560323 A JP 2021560323A JP 2021560323 A JP2021560323 A JP 2021560323A JP 2022527638 A5 JP2022527638 A5 JP 2022527638A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- salt
- phospholipid
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962826874P | 2019-03-29 | 2019-03-29 | |
| US62/826,874 | 2019-03-29 | ||
| PCT/US2020/025246 WO2020205530A1 (en) | 2019-03-29 | 2020-03-27 | Liposomal formulations, and methods of using and preparing thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527638A JP2022527638A (ja) | 2022-06-02 |
| JP2022527638A5 true JP2022527638A5 (cg-RX-API-DMAC7.html) | 2023-04-03 |
| JP7583741B2 JP7583741B2 (ja) | 2024-11-14 |
Family
ID=72666933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560323A Active JP7583741B2 (ja) | 2019-03-29 | 2020-03-27 | リポソーム製剤、ならびにリポソーム製剤を使用および調製する方法 |
Country Status (19)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021011876A (es) | 2019-03-29 | 2022-01-04 | Glycomine Inc | Formulaciones liposomicas y metodos de uso y preparacion de las mismas. |
| US20250248939A1 (en) * | 2022-04-18 | 2025-08-07 | City Of Hope | Lipid nanoparticles, nucleic acids, and methods of use |
| TW202543582A (zh) * | 2024-02-29 | 2025-11-16 | 美商葛里柯麥公司 | 脂質體調配物及其使用及製備方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5997899A (en) | 1996-10-01 | 1999-12-07 | Skyepharma Inc. | Method for producing liposomes with increased percent of compound encapsulated |
| WO2000051565A1 (en) | 1999-03-02 | 2000-09-08 | The Liposome Company, Inc. | Encapsulation of bioactive complexes in liposomes |
| US7060291B1 (en) * | 1999-11-24 | 2006-06-13 | Transave, Inc. | Modular targeted liposomal delivery system |
| US7189705B2 (en) | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
| US7011845B2 (en) | 2000-05-09 | 2006-03-14 | Mcp Hahnemann University | β-glucans encapsulated in liposomes |
| HUP0303616A3 (en) | 2001-03-26 | 2006-07-28 | Alza Corp Mountain View | Liposome composition for improved intracellular delivery of a therapeutic agent |
| CA2471960A1 (en) | 2002-01-09 | 2003-07-24 | Elan Pharmaceuticals, Inc. | Efficient liposomal encapsulation |
| EP1478341A4 (en) | 2002-01-09 | 2009-05-20 | Transave Inc | EFFICIENT ENCAPSULATION OF NUCLEIC ACIDS IN MEDIUM SIZE LIPOSOMES |
| WO2004103510A2 (en) | 2003-05-14 | 2004-12-02 | The Regents Of The University Of Colorado | Methods and apparatus using electrostatic atomization to form liquid vesicles |
| EP1643971A2 (en) | 2003-05-22 | 2006-04-12 | Neopharm, Inc. | Liposomal formulations comprising a combination of two or more active agents |
| JP2008518925A (ja) | 2004-10-29 | 2008-06-05 | ネオファーム、インコーポレイティッド | リポソーム製剤の製造プロセス |
| FR2897779B1 (fr) | 2006-02-24 | 2009-04-17 | Orphan Europ Sarl | Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la |
| KR20100127842A (ko) | 2008-03-26 | 2010-12-06 | 유니버시티 오브 옥스퍼드 | 소포체 표적화 리포좀 |
| CA2761916A1 (fr) * | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Procede pour adjuver le lipopolysaccharide (lps) des bacteries a gram-negatif |
| WO2010138550A1 (en) | 2009-05-27 | 2010-12-02 | Northeastern University | Conjugated nanodelivery vehicles |
| WO2011076807A2 (en) | 2009-12-23 | 2011-06-30 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
| US20110257233A1 (en) | 2010-03-19 | 2011-10-20 | Sanford-Burnham Medical Research Institute | Benzoisothiazolones as inhibitors of phosphomannose isomerase |
| EP2598120B1 (en) | 2010-07-31 | 2018-09-05 | The Scripps Research Institute | Compositions and methods for inducing immune tolerance |
| PT2750707T (pt) | 2011-08-31 | 2019-01-23 | Glaxosmithkline Biologicals Sa | Lipossomas peguilados para distribuição de arn que codifica imunogénio |
| HK1206644A1 (en) | 2012-03-29 | 2016-01-15 | Shire Human Genetic Therapies, Inc. | Lipid-derived neutral nanoparticles |
| WO2014063757A1 (en) | 2012-10-26 | 2014-05-01 | Universiteit Leiden | Delivery methods |
| CN104884637A (zh) | 2012-11-05 | 2015-09-02 | 普隆奈治疗公司 | 利用生物标志物通过bcl2表达的调节治疗癌症的方法 |
| ES3026657T3 (en) | 2013-09-16 | 2025-06-11 | Glycomine Inc | Pharmaceutical preparation of carbohydrates for therapeutic use |
| US20150132369A1 (en) | 2013-11-09 | 2015-05-14 | Exir Nano Sina Company | Nanoliposomal cyclosorin formulations for immunosuppresion and methods for the production thereof |
| CN107207614B (zh) | 2014-10-09 | 2022-01-11 | 利普泰克有限公司 | 嵌合蛋白 |
| US20170165374A1 (en) | 2015-11-18 | 2017-06-15 | Insmed, Inc. | Compositions and methods for treating bacterial infections |
| MX2021011876A (es) | 2019-03-29 | 2022-01-04 | Glycomine Inc | Formulaciones liposomicas y metodos de uso y preparacion de las mismas. |
-
2020
- 2020-03-27 MX MX2021011876A patent/MX2021011876A/es unknown
- 2020-03-27 EP EP20782039.0A patent/EP3946365A4/en active Pending
- 2020-03-27 US US17/593,755 patent/US12691131B2/en active Active
- 2020-03-27 AR ARP200100841A patent/AR119705A1/es unknown
- 2020-03-27 TW TW109110461A patent/TWI906214B/zh active
- 2020-03-27 AU AU2020252005A patent/AU2020252005B2/en active Active
- 2020-03-27 BR BR112021019593A patent/BR112021019593A2/pt unknown
- 2020-03-27 SG SG11202110623PA patent/SG11202110623PA/en unknown
- 2020-03-27 PE PE2021001645A patent/PE20212366A1/es unknown
- 2020-03-27 EA EA202192663A patent/EA202192663A1/ru unknown
- 2020-03-27 WO PCT/US2020/025246 patent/WO2020205530A1/en not_active Ceased
- 2020-03-27 CN CN202080038191.4A patent/CN113873998A/zh active Pending
- 2020-03-27 PH PH1/2021/552428A patent/PH12021552428A1/en unknown
- 2020-03-27 KR KR1020217035257A patent/KR20210143906A/ko active Pending
- 2020-03-27 CA CA3134828A patent/CA3134828A1/en active Pending
- 2020-03-27 JP JP2021560323A patent/JP7583741B2/ja active Active
- 2020-03-27 IL IL286713A patent/IL286713B2/en unknown
-
2021
- 2021-09-28 CL CL2021002512A patent/CL2021002512A1/es unknown
- 2021-10-26 CO CONC2021/0014274A patent/CO2021014274A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2772965C (en) | Medical use of spla2 hydrolysable liposomes | |
| US20110237510A1 (en) | Stabilized glucagon solutions | |
| JP2014519493A (ja) | ポリマー共役脂質を含むリポソームおよび関連用途 | |
| US8912162B2 (en) | Parenteral formulations of elacytarabine derivatives | |
| JP5735724B2 (ja) | 腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法 | |
| JP2008534525A (ja) | リン脂質のポリエチレングリコール誘導体に包み込まれたアンスラサイクリン系抗腫瘍抗生物質のナノミセル製剤 | |
| KR100520738B1 (ko) | 간염 치료제 | |
| US8241663B2 (en) | Liposome preparation | |
| JP2022527638A (ja) | リポソーム製剤、ならびにリポソーム製剤を使用および調製する方法 | |
| JPWO2005021012A1 (ja) | ゲムシタビン封入薬剤担体 | |
| JP2009530318A (ja) | 加水分解時に分子内環化反応を行うホスホリパーゼa2分解性脂質を含む脂質ベース薬剤送達系 | |
| TW202143978A (zh) | 格列本脲脂質體組合物及其製備方法 | |
| JP2025506429A5 (cg-RX-API-DMAC7.html) | ||
| EP1594488B1 (en) | Stabilized pharmaceutical compositions of safingol and methods of using the same | |
| US20240261311A1 (en) | Methods of treating or preventing allergies and chronic nasal congestion | |
| TH2101006052A (th) | สูตรผสมไลโปโซม, และวิธีการใช้และการเตรียมของสิ่งดังกล่าว | |
| Sandal et al. | Liposomal drug delivery: recent developments and challenges | |
| JPH04356421A (ja) | プロスタグランジン類含有脂肪小体組成物 | |
| EP4667475A1 (en) | Ph-responsive phospholipid | |
| CN101014322A (zh) | 盐水中富含固醇的添加两性霉素的混合层状脂质体及其制备方法 | |
| US20250228902A1 (en) | Combination drug for treating malignant tumor | |
| JPH0574573B2 (cg-RX-API-DMAC7.html) | ||
| JP2000302685A (ja) | 抗腫瘍薬含有リポソーム製剤 | |
| JPH11199488A (ja) | 抗腫瘍薬のリポソーム化製剤 | |
| CN104546719A (zh) | 一种载Z-GP-Dox的混合胶束制剂及其制备方法 |